Trials / Terminated
TerminatedNCT00449111
An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)
An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate blood pressure after 6 weeks of treatment with COZAAR plus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0954, losartan potassium / Duration of Treatment - 12 weeks |
Timeline
- Start date
- 2006-03-13
- Primary completion
- 2006-09-30
- Completion
- 2006-09-30
- First posted
- 2007-03-19
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00449111. Inclusion in this directory is not an endorsement.